The AE-8 trapped electron model environment, NSSDC/WDC-A-R&S 91-24 (1991)
Controls were untreated, and showing 100% growth, while tests measured percentage decrease in bacterial growth with respect to this control
Zaha, I., Muresan, M., Tulcan, C., Huniadi, A., Naghi, P., Sandor, M., Tripon, R., Gaspar, C., Klaudia-Melinda, M., Sachelarie, L., & Stefan, L
In the realm of cell-based therapies and antibodydrug conjugates (ADCs), CT041, a CLDN18.2-targeted CAR-T product, is being studied in gastrointestinal cancers (NCT04404595), while enfortumab vedotin, targeting Nectin-4, is under investigation for metastatic castration-resistant prostate cancer (NCT04754191)
Its metabolism interfaces with the folate cycle, cobalamin remethylation, and the synthesis of S-adenosylmethionine (SAM)